We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+10.94%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.38B
AUM Growth
+$250M
Cap. Flow
-$95M
Cap. Flow %
-1.49%
Top 10 Hldgs %
24.3%
Holding
176
New
25
Increased
62
Reduced
40
Closed
19

Top Buys

Rank Stock Value
1
GTLB icon
GitLab
GTLB
+$45.6M
2
ROL icon
Rollins
ROL
+$37.7M
3
CPRT icon
Copart
CPRT
+$36.7M
4
MDB icon
MongoDB
MDB
+$36.7M
5
TTD icon
Trade Desk
TTD
+$36.6M

Top Sells

Rank Stock Value
1
CRWD icon
CrowdStrike
CRWD
+$76.4M
2
PANW icon
Palo Alto Networks
PANW
+$64.1M
3
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$60.1M
4
LNG icon
Cheniere Energy
LNG
+$51.4M
5
APTV icon
Aptiv
APTV
+$43.1M

Sector Composition

Rank Sector Weight
1 Healthcare 38.57%
2 Technology 24.76%
3 Industrials 16.51%
4 Consumer Discretionary 8.57%
5 Communication Services 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSP icon
76
Inspire Medical Systems
INSP
$1.44B
$26.9M 0.42%
125,090
– –
VST icon
77
Vistra
VST
$50.1B
$26M 0.41%
372,861
+79,954
+27% +$3.96M
WDAY icon
78
Workday
WDAY
$39B
$25.8M 0.4%
94,551
+87
+0.1% +$24.8K
FDMT icon
79
4D Molecular Therapeutics
FDMT
$526M
$24.7M 0.39%
+776,114
New +$19.8M
INZY
80
DELISTED
Inozyme Pharma
INZY
$24.4M 0.38%
3,179,837
– –
KRYS icon
81
Krystal Biotech
KRYS
$10.8B
$24.3M 0.38%
136,485
– –
STE icon
82
Steris
STE
$22.5B
$22.2M 0.35%
98,873
– –
BBIO icon
83
BridgeBio Pharma
BBIO
$16.1B
$22.2M 0.35%
716,927
– –
NOVT icon
84
Novanta
NOVT
$4.95B
$22.1M 0.35%
126,359
+339
+0.3% +$55.6K
BPMC
85
DELISTED
Blueprint Medicines
BPMC
$22M 0.34%
231,685
-80,689
-26% -$6.92M
BHVN icon
86
Biohaven
BHVN
$2.08B
$21.9M 0.34%
401,101
– –
RGEN icon
87
Repligen
RGEN
$8.1B
$21.9M 0.34%
119,000
– –
RELY icon
88
Remitly
RELY
$4.94B
$21.3M 0.33%
+1,028,678
New +$19.5M
MRNS
89
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$21.2M 0.33%
2,346,526
-2,183,471
-48% -$21.2M
RPRX icon
90
Royalty Pharma
RPRX
$26.2B
$21M 0.33%
690,687
+156,712
+29% +$4.62M
VKTX icon
91
Viking Therapeutics
VKTX
$3.86B
$20.7M 0.33%
252,969
-497,031
-66% -$22.1M
CERE
92
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$20.7M 0.32%
490,000
– –
MBLY icon
93
Mobileye
MBLY
$1.99B
$20.3M 0.32%
+631,379
New +$17.9M
APTV icon
94
Aptiv
APTV
$12.3B
$20M 0.31%
250,675
-534,798
-68% -$43.1M
IRM icon
95
Iron Mountain
IRM
$37.1B
$19.9M 0.31%
+247,702
New +$17.9M
BRKR icon
96
Bruker
BRKR
$9.79B
$19.8M 0.31%
210,362
-3
-0% -$241
PRVA icon
97
Privia Health
PRVA
$3.01B
$19.6M 0.31%
1,000,000
– –
ESI icon
98
Element Solutions
ESI
$8.68B
$18.4M 0.29%
737,915
-44,410
-6% -$1.03M
CYTK icon
99
Cytokinetics
CYTK
$10.9B
$17.8M 0.28%
254,148
-301,852
-54% -$23.3M
RCM
100
DELISTED
R1 RCM Inc. Common Stock
RCM
$17.7M 0.28%
1,375,980
– –
2 3
4
5 6

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, Eventide Asset Management held 176 positions worth $6.38B, up 4.1% from $6.13B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management's Q1 2024 filing shows 25 new, 62 increased, 40 reduced and 19 closed positions. Its largest new stake was GitLab: 695,704 shares worth $40.6M. The largest sale was CrowdStrike, an estimated $76.4M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q1 2024 buy was GitLab: 695,704 shares worth $40.6M.
  • Eventide Asset Management added most to Rollins in Q1 2024, an estimated $37.7M increase.
  • Eventide Asset Management's biggest Q1 2024 reduction was CrowdStrike, cutting an estimated $76.4M.
  • Eventide Asset Management fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $60.1M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $6.38B portfolio in Q1 2024.
  • Eventide Asset Management opened 25 new positions and closed 19 in Q1 2024.
  • Eventide Asset Management's portfolio value rose 4.1% quarter-over-quarter to $6.38B.

Based on Eventide Asset Management's 13F filing for Q1 2024, filed 15 May 2024.